Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature Medicine 12, 1410 - 1416 (2006)
Published online: 26 November 2006 | doi:10.1038/nm1515
Regulation of osteoclast differentiation and function by the CaMK-CREB pathway
Kojiro Sato1,11, Ayako Suematsu1,11, Tomoki Nakashima1, Sayaka Takemoto-Kimura2, Kazuhiro Aoki3, Yasuyuki Morishita4, Hiroshi Asahara5, Keiichi Ohya3, Akira Yamaguchi6, Toshiyuki Takai7, Tatsuhiko Kodama8, Talal A Chatila9, Haruhiko Bito2,10 & Hiroshi Takayanagi1,10
Abstract
Calcium (Ca2+) signaling is essential for a variety of cellular responses and higher biological functions. Ca2+/calmodulin-dependent kinases (CaMKs) and the phosphatase calcineurin activate distinct downstream pathways that are mediated by the transcription factors cAMP response element (CRE)-binding protein (CREB) and nuclear factor of activated T cells (NFAT), respectively1. The importance of the calcineurin-NFAT pathway in bone metabolism has been demonstrated in osteoclasts, osteoblasts and chondrocytes2, 3, 4, 5. However, the contribution of the CaMK-CREB pathway is poorly understood, partly because of the difficulty of dissecting the functions of homologous family members6, 7, 8. Here we show that the CaMKIV-CREB pathway is crucial for osteoclast differentiation and function. Pharmacological inhibition of CaMKs as well as the genetic ablation of Camk4 reduced CREB phosphorylation and downregulated the expression of c-Fos, which is required for the induction of NFATc1 (the master transcription factor for osteoclastogenesis2, 3) that is activated by receptor activator of NF-
B ligand (RANKL). Furthermore, CREB together with NFATc1 induced the expression of specific genes expressed by differentiated osteoclasts. Thus, the CaMK-CREB pathway biphasically functions to regulate the transcriptional program of osteoclastic bone resorption, by not only enhancing induction of NFATc1 but also facilitating NFATc1-dependent gene regulation once its expression is induced. This provides a molecular basis for a new therapeutic strategy for bone diseases.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Medicine Interfering with bone remodellingNature News and Views (18 Apr 2002)
Arming the osteoclastNature Medicine News and Views (01 May 2004)
See all 7 matches for News And ViewsRESEARCH
Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activationNature Medicine Article (01 Mar 2009)
See all 51 matches for Research